Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 6
Emerging treatment options for early mycosis fungoides
Authors Fernandez-Guarino M
Received 2 July 2012
Accepted for publication 3 August 2012
Published 18 February 2013 Volume 2013:6 Pages 61—69
DOI https://doi.org/10.2147/CCID.S27482
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Montserrat Fernandez-Guarino
Department of Dermatology, Hospital Central de la Cruz Roja, Madrid, Spain
Abstract: Mycosis fungoides is a candidate for skin-directed therapies in its initial stages. In recent years, therapeutic options outside of the normal treatment recommendations such as topical imiquimod, topical tazarotene, topical methotrexate, excimer light sources, and photodynamic therapy have been published with variable results. These alternatives have been useful in cases of localized mycosis fungoides that do not respond to routine treatments; nevertheless, more studies on these methods are still needed. This article summarizes the literature and data that are known so far about these treatments.
Keywords: mycosis fungoides, topical treatments, excimer light, photodynamic therapy
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.